The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustion
Open Access
- 27 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 26 (7) , 1139-1151
Abstract
CD8+ T cell exhaustion (Tex) limits immune control of cancer, but the underlying molecular drivers are unclear. In the present study, we identified the prostaglandin I2 (prostacyclin) receptor PTGIR as a cell-intrinsic regulator of T cell exhaustion. Transcriptomic profiling of terminally exhausted (Ttex) CD8+ T cells revealed increased activation of the nuclear factor erythroid 2-related factor 2 (NRF2) oxidative stress response pathway. Enhancing NRF2 activity (by conditional deletion of Kelch-like ECH-associated protein 1 (KEAP1)) boosts glutathione production in CD8+ T cells but accelerates terminal exhaustion. NRF2 upregulates PTGIR expression in CD8+ T cells. Silencing PTGIR expression enhances T cell effector function (that is, interferon-γ and granzyme production) and limits Ttex cell development in chronic infection and cancer models. Mechanistically, PTGIR signaling impairs T cell metabolism and cytokine production while inducing transcriptional features of Tex cells. These findings identify PTGIR as a NRF2-dependent immune checkpoint that regulates balance between effector and exhausted CD8+ T cell states.Keywords
Funding Information
- Allen Family Philanthropies
- Van Andel Institute
- Gouvernement du Canada | Canadian Institutes of Health Research (MFE-403514, MFE-181903)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R21AI153997, AI154450, AI158294)
- Cancer Prevention and Research Institute of Texas (RR210035)
- University of Texas Southwestern Medical Center
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG056524)
- V Foundation for Cancer Research
- American Federation for Aging Research
- Cancer Research Institute
This publication has 58 references indexed in Scilit:
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- A pipeline for the generation of shRNA transgenic miceNature Protocols, 2012
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variationNucleic Acids Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysisNucleic Acids Research, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Identification of ROS Using Oxidized DCFDA and Flow-Cytometry2009
- Nrf1 and Nrf2 Regulate Rat Glutamate-Cysteine Ligase Catalytic Subunit Transcription Indirectly via NF-κB and AP-1Molecular and Cellular Biology, 2005
- Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene ExpressionJournal of Biological Chemistry, 2003
- Prostacyclin: its biosynthesis, actions and clinical potentialPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1981